BFRI (STOCKS)
Biofrontera Inc. Common Stock
$1.320000
+0.070000 (+5.60%)
Prev close: $1.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Hermann Lübbert
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16.81M
- Employees
- 93
- P/E (TTM)
- -1.13
- P/B (TTM)
- 2.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.05 | $-0.11 | +0.0571 | +53.31% |
|
Mar 2026 (Q1)
|
$-0.37 | $-0.12 | -0.2527 | -215.43% |
|
Dec 2025 (Q4)
|
$0.48 | $0.20 | +0.2841 | +142.84% |
|
Sep 2025 (Q3)
|
$-0.62 | $-0.59 | -0.0284 | -4.80% |
Financial Statements
| Revenues | $43.20M |
| Benefits Costs and Expenses | $54.26M |
| Costs And Expenses | $54.32M |
| Nonoperating Income/Loss | $62.00K |
| Operating Expenses | $54.32M |
| Selling, General, and Administrative Expenses | $40.09M |
| Research and Development | $3.41M |
| Other Operating Expenses | $10.82M |
| Operating Income/Loss | -$11.12M |
| Income/Loss From Continuing Operations After Tax | -$11.08M |
| Income/Loss From Continuing Operations Before Tax | -$11.06M |
| Net Income/Loss | -$11.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.98 |
| Diluted Earnings Per Share | -$0.98 |
| Basic Average Shares | 12,981,312 |
| Diluted Average Shares | 12,981,312 |
| Assets | $24.79M |
| Current Assets | $13.16M |
| Inventory | $1.23M |
| Other Current Assets | $11.93M |
| Noncurrent Assets | $11.63M |
| Fixed Assets | $2.18M |
| Intangible Assets | $2.61M |
| Other Non-current Assets | $6.84M |
| Liabilities | $18.72M |
| Current Liabilities | $10.92M |
| Wages | $3.53M |
| Other Current Liabilities | $7.39M |
| Noncurrent Liabilities | $7.79M |
| Equity | $6.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.07M |
| Liabilities And Equity | $24.79M |
| Net Cash Flow From Operating Activities | -$9.31M |
| Net Cash Flow From Operating Activities, Continuing | -$9.31M |
| Net Cash Flow From Investing Activities | $3.00M |
| Net Cash Flow From Investing Activities, Continuing | $3.00M |
| Net Cash Flow From Financing Activities | $6.81M |
| Net Cash Flow From Financing Activities, Continuing | $6.81M |
| Net Cash Flow | $487.00K |
| Net Cash Flow, Continuing | $487.00K |
| Comprehensive Income/Loss | -$11.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.09M |
| Other Comprehensive Income/Loss | $0.00 |